The BEST (Biomarkers, EndpointS, and other Tools) Framework. In 2016, the FDA and NIH collaborated to draft “Biomarkers, EndpointS, and other Tools (BEST),” which contains a description of seven types of biomarkers. All of these biomarkers could be measured using digital tools, which results in a digital biomarker.